2 domains / 4 areas / 2 specializations
Sheppard Pratt Health System
Data updated
Sheppard Pratt Health System is a leading non-profit psychiatric hospital and health system in Towson, Maryland, home to the Center of Excellence for Psilocybin Research and Treatment — the first international center of its kind — established in partnership with COMPASS Pathways; it has conducted landmark psilocybin trials including the first trial for bipolar type II depression (published in JAMA Psychiatry with 80% remission at 12 weeks), psilocybin for treatment-resistant depression (published in NEJM), and psilocybin for TRD with chronic suicidal ideation.
Academic Research
0 papersPublished Papers
0
Trial Involvement
3
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Care Delivery Snapshot
Health Systems & HospitalsProvider Model
Health System / Hospital Program
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Payer Models
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Quick Facts
- Type
- Other
- HQ
- United States
- Website
- Visit